Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-09-14 06:13 am Sale | 13D | MOLECULAR TEMPLATES INC NE MTEM | TAKEDA PHARMACEUTICAL CO LTD TAK | 2,314,659 4.1% | -608,334 (-20.81%) | View |
| 2021-04-26 1:11 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | BB BIOTECH AG | 9,542,621 17% | 3,162,290 (+49.56%) | View |
| 2021-02-16 3:41 pm Sale | 13G | MOLECULAR TEMPLATES INC NE MTEM | PERCEPTIVE ADVISORS LLC | 601,818 1.2% | -2,562,315 (-80.98%) | View |
| 2021-02-12 5:07 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | BB BIOTECH AG | 6,380,331 12.8% | 1,150,335 (+21.99%) | View |
| 2021-02-11 5:23 pm Sale | 13G | MOLECULAR TEMPLATES INC NE MTEM | BIOTECHNOLOGY VALUE FUND L P | 2,761,121 5.5% | -847,211 (-23.48%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | BlackRock Inc. BLK | 3,078,709 6.2% | 3,078,709 (New Position) | View |
| 2020-11-03 5:33 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | BB BIOTECH AG | 5,229,996 10.5% | 3,068,844 (+142.00%) | View |
| 2020-09-18 4:48 pm Sale | 13D | MOLECULAR TEMPLATES INC NE MTEM | SANTE HEALTH VENTURES I LP | 7,091,100 15.5% | -772,500 (-9.82%) | View |
| 2020-06-05 5:11 pm Sale | 13D | MOLECULAR TEMPLATES INC NE MTEM | Longitude Capital Partners III LLC | 4,703,951 10% | -983,351 (-17.29%) | View |
| 2020-05-04 5:11 pm Sale | 13D | MOLECULAR TEMPLATES INC NE MTEM | SANTE HEALTH VENTURES I LP | 7,863,600 17.2% | -898,363 (-10.25%) | View |
| 2020-02-14 4:18 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | PERCEPTIVE ADVISORS LLC | 3,164,133 7.3% | 1,000,000 (+46.21%) | View |
| 2020-02-14 3:21 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | BIOTECHNOLOGY VALUE FUND L P | 3,608,332 8.2% | 243,911 (+7.25%) | View |
| 2020-01-29 4:34 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | BB BIOTECH AG | 2,161,152 5.03% | 2,161,152 (New Position) | View |
| 2019-12-05 4:29 pm Purchase | 13D | MOLECULAR TEMPLATES INC NE MTEM | Longitude Capital Partners III LLC | 5,687,302 12.5% | 965,000 (+20.43%) | View |